BioSpace News Archive

Press Releases

ADMA Biologics to Participate in the Raymond James Institutional Investor Conference

March 3, 2025
·
2 min read
Press Releases

Opthea Reports Half Year Results and Business Updates

March 3, 2025
·
16 min read
Press Releases

Vertex Receives CHMP Positive Opinion for Expanded Label for KAFTRIO® in Combination With Ivacaftor for People With Cystic Fibrosis to Include Rare Mutations

March 3, 2025
·
6 min read
Press Releases

Novartis oral Fabhalta® (iptacopan) receives positive CHMP opinion for the treatment of adults living with C3 glomerulopathy (C3G)

March 3, 2025
·
12 min read
Press Releases

Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa

March 3, 2025
·
7 min read
Press Releases

Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025

March 3, 2025
·
1 min read
Press Releases

Zimmer Biomet to Present at the 27th Annual Barclays Healthcare Conference

March 3, 2025
·
1 min read
Press Releases

BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of RAS and PI3Kα-Targeting Medicines

March 3, 2025
·
14 min read
Press Releases

Outlook Therapeutics® Re-Submits Biologics License Application for ONS-5010 as a Treatment for Wet AMD to the U.S. Food and Drug Administration

March 3, 2025
·
7 min read
Press Releases

CHMP recommends EU approval of Roche’s Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma

March 3, 2025
·
10 min read